Slowly Progressing Type 1 Diabetes: Persistence of Islet Cell Autoantibodies is Related to Glibenclamide Treatment.
Saved in:
| Title: | Slowly Progressing Type 1 Diabetes: Persistence of Islet Cell Autoantibodies is Related to Glibenclamide Treatment. |
|---|---|
| Authors: | Cabrera-Rode, Eduardo1, Perich, Pedro1, Diaz-Horta, Oscar1, Tiberti, Claudio2, Molina, Gisela1, Arranz, Celeste1, Martin, Juana M.1, Licea, Manuel1, De Leiva, Alberto3, Puig-Domingo, Manuel3, Dimario, Umberto2 |
| Source: | Autoimmunity. Nov2002, Vol. 35 Issue 7, p469-474. 6p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
